We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$254B
AUM Growth
+$235B
(+1,256%)
Cap. Flow
+$230B
Cap. Flow
% of AUM
90.52%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
3,268
New
2,228
Increased
916
Reduced
59
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.24B |
| 2 |
Apple
AAPL
|
+$6.76B |
| 3 |
Amazon
AMZN
|
+$6.52B |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$3.45B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$142M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$40.1M |
| 3 |
Nuveen ESG Large-Cap Value ETF
NULV
|
+$22M |
| 4 |
Nuveen ESG Small-Cap ETF
NUSC
|
+$20.8M |
| 5 |
Nuveen ESG Large-Cap Growth ETF
NULG
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.97% |
| 2 | Financials | 14.46% |
| 3 | Healthcare | 12.78% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
2151
Trueblue
TBI
$317M
| $3.69M | ﹤0.01% |
+167,036
| New | +$3.88M |
|
2152
Assembly Biosciences
ASMB
$527M
| $3.68M | ﹤0.01% |
+22,739
| New | +$4.32M |
|
2153
ePlus
PLUS
$2.38B
| $3.66M | ﹤0.01% |
+106,054
| New | +$4.41M |
|
2154
ORIX
IX
$43.2B
| $3.63M | ﹤0.01% |
+242,595
| New | +$3.47M |
|
2155
Denali Therapeutics
DNLI
$3.94B
| $3.63M | ﹤0.01% |
+174,975
| New | +$3.92M |
|
2156
Cerus
CERS
$488M
| $3.63M | ﹤0.01% |
+645,794
| New | +$3.57M |
|
2157
Pitney Bowes
PBI
$2.35B
| $3.63M | ﹤0.01% |
+848,100
| New | +$4.55M |
|
2158
QuinStreet
QNST
$1.24B
| $3.62M | ﹤0.01% |
228,597
+211,950
| +1,273% | +$3.16M |
|
|
ACR
2159
ACRES Commercial Realty
ACR
$104M
| $3.62M | ﹤0.01% |
+106,735
| New | +$3.53M |
|
2160
Lloyds Banking Group
LYG
$89.3B
| $3.61M | ﹤0.01% |
+1,271,287
| New | +$3.93M |
|
2161
Theravance Biopharma
TBPH
$875M
| $3.61M | ﹤0.01% |
+221,092
| New | +$4.48M |
|
2162
Unisys
UIS
$216M
| $3.6M | ﹤0.01% |
+370,350
| New | +$3.82M |
|
|
BVH
2163
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $3.6M | ﹤0.01% |
+146,625
| New | +$3.75M |
|
2164
Standex International
SXI
$4.07B
| $3.6M | ﹤0.01% |
+49,179
| New | +$3.47M |
|
2165
Caleres
CAL
$492M
| $3.58M | ﹤0.01% |
+179,442
| New | +$4.15M |
|
2166
Hyster-Yale Materials Handling
HY
$642M
| $3.56M | ﹤0.01% |
+64,492
| New | +$3.6M |
|
|
TRST
2167
Trustco Bank Corp NY
TRST
$938M
| $3.56M | ﹤0.01% |
+89,949
| New | +$3.49M |
|
|
GOOD
2168
Gladstone Commercial Corp
GOOD
$618M
| $3.55M | ﹤0.01% |
+167,359
| New | +$3.56M |
|
|
OLP
2169
One Liberty Properties
OLP
$510M
| $3.54M | ﹤0.01% |
+122,162
| New | +$3.53M |
|
2170
Inspire Medical Systems
INSP
$1.75B
| $3.53M | ﹤0.01% |
+58,136
| New | +$3.13M |
|
|
GTHX
2171
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.5M | ﹤0.01% |
+114,328
| New | +$2.41M |
|
2172
Coeur Mining
CDE
$18.4B
| $3.49M | ﹤0.01% |
+804,955
| New | +$2.83M |
|
2173
Regional Management Corp
RM
$291M
| $3.49M | ﹤0.01% |
132,433
+120,923
| +1,051% | +$3.01M |
|
|
SHYF
2174
DELISTED
The Shyft Group
SHYF
| $3.49M | ﹤0.01% |
318,459
+282,629
| +789% | +$2.6M |
|
2175
American Public Education
APEI
$935M
| $3.47M | ﹤0.01% |
+117,320
| New | +$3.59M |
|
Similar funds
VFT
Nuveen's Q2 2019 Portfolio in Review
As of Q2 2019, Nuveen held 3,268 positions worth $254B, up 1,256% from $18.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Nuveen deployed $230B of net new capital in Q2 2019, opening 2,228 new positions and adding to 916 existing holdings. Its largest new stake was Netflix: 33,941,080 shares worth $1.25B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $142M trimmed.
- Nuveen's largest Q2 2019 buy was Netflix: 33,941,080 shares worth $1.25B.
- Nuveen added most to Microsoft in Q2 2019, an estimated $8.24B increase.
- Nuveen's biggest Q2 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $142M.
- Nuveen fully exited Nuveen ESG Large-Cap Value ETF in Q2 2019, selling an estimated $22M.
- Nuveen's ten largest holdings make up 17% of its $254B portfolio in Q2 2019.
- Nuveen opened 2,228 new positions and closed 11 in Q2 2019.
- Nuveen's portfolio value rose 1,256% quarter-over-quarter to $254B.
Based on Nuveen's 13F filing for Q2 2019, filed 15 Aug 2019.